Skip to Main Content

STAT Trials Pulse provides life science professionals with early signals about clinical development, accelerating decision-making on partnerships, regulatory strategy, investment, and more.

STAT and Applied XL bring you STAT Trials Pulse
The new clinical intelligence platform uses machine learning to mine the clinical trials space for actionable data, and surface emerging trends ahead of standard systems. A new way to track clinical trials and gather actionable intelligence.

Since 2015, our team at STAT has worked tirelessly to deliver trusted and authoritative journalism about health, medicine, and the life sciences to millions of readers around the world. Today we are thrilled to unveil a new product that has been under development for over a year and that we believe will transform how readers like you track and analyze clinical trials data: STAT Trials Pulse

Developed by artificial intelligence company Applied XL, in conjunction with STAT’s national biotech team, STAT Trials Pulse uses machine learning and editorial-driven algorithms to help life sciences and health care professionals identify, in real-time, the most important updates happening in the clinical trials space. 

“Our team has created a product that merges machine learning and computational journalism. There is a growing demand for current and transparent information in the scientific and research community. STAT Trials Pulse fulfills these needs, giving users an unbeatable competitive advantage,” said Francesco Marconi, Co-Founder & CEO of Applied XL.  

Users who access the platform can build personalized, dynamic feeds to monitor the specific conditions, interventions, and organizations that matter most to them. They can also use a proprietary discovery tool to surface noteworthy trends in the clinical trial space, identify emerging research activity, and detect disruptions to company pipelines. And, crucially, they receive these updates in real-time, through contextualized alerts that announce when studies stop unexpectedly, or when there are changes in completion dates, enrollment, and more. You can see a full list of features at

“Our mission at STAT has always been to provide readers with leading coverage on health, science, and medicine. Now, STAT is expanding beyond reporting. With STAT Trials Pulse, our organization has taken a huge step in providing industry professionals with the insights and knowledge they need to succeed. Today’s announcement is a game-changer for how we use technology to acquire information,” said Rick Berke, STAT co-founder and executive editor.

The platform’s annual cost is $1,500 per year. STAT Trials Pulse is available for a four-week free trial to all new users who sign up. Get started at